Nephrology News
Liraglutide Linked With Lower Diabetic Kidney Disease Risk
Liraglutide-treated patients were 22% less likely than placebo recipients to experience a composite outcome of renal events.
By accepting you will be accessing a service provided by a third-party external to https://galencarepartners.com/